Dr Mohammed Hajaj
NCI Clinical Lead for Breast
Dr Mohamad Hajaj is the Clinical Lead for Breast Imaging at National Clinical Insourcing (NCI), where he brings over 20 years of diagnostic leadership, service innovation, and international expertise in breast radiology to support NHS trusts in delivering high-quality, safe, and efficient breast services.
A dual-qualified consultant with a CCST in Clinical Radiology and an Executive MBA in Health Leadership, Dr Hajaj combines deep clinical expertise with strong strategic acumen. He served as Clinical Director of the Jarvis Breast Screening Centre in Surrey and holds visiting consultant appointments at the Nottingham Breast Institute and University Hospitals Birmingham. He is also a European Diploma holder in Breast Imaging (EDBI) and a respected faculty member at international breast imaging workshops, where he regularly trains radiologists in advanced diagnostic techniques.
Over the course of his career, Dr Hajaj has held a series of senior NHS and international leadership positions, including Director of Breast Imaging Fellowship Programmes and Head of Clinical Governance. He has spearheaded multiple service transformations, from the digitalisation of breast screening and introduction of contrast-enhanced spectral mammography (CESM) to the establishment of breast MRI-guided biopsy services and development of one-stop breast clinics. Each of these initiatives has been designed to improve patient pathways, accelerate diagnosis, and ensure robust governance standards.
At NCI, Dr Hajaj leads the national Breast Imaging service. Most recently, he has been instrumental in the delivery of NCI’s partnership with South Tees NHS Foundation Trust, where he has overseen significant improvements to both symptomatic and screening pathways. Under his leadership, the service has introduced strengthened audit and discrepancy processes, enhanced quality assurance measures, and optimised patient flow—all contributing to safer care, higher diagnostic accuracy, and meaningful support for elective recovery targets.